Lonza's exclusive synthesis small-scale plant to come on stream
Lonza's exclusive synthesis small-scale at Nansha Guangzhou, China, is on schedule to come on stream in September 2007.
Lonza's exclusive synthesis small-scale at Nansha Guangzhou, China, is on schedule to come on stream in September 2007.
The world-class facility will offer an integrated exclusive synthesis platform with r&d capabilities as well as small and large scale cGMP manufacturing. It is designed to accommodate a greater number of reactors, including a dedicated and technologically advanced Quality Control lab capable of fulfilling the ever-increasing requirements of global regulatory authorities on the highest possible level.
In the completed first build-out phase, six smaller reactors including distillation and filtration units have been installed, capable of handling a broad range of technologies. The configuration ensures fast changeover, optimised efficiencies and extremely rapid technical transfer to commercial assets. Additional capacity can be added without affecting running operations.
The plant is designed for production of quantities from 10kg up to several hundreds of kilograms, and closes the gap between Nansha's kilo lab and commercial production assets to allow complete life-cycle support for pharmaceutical products out of China. The commercial scale API facility in Nansha is currently under construction and will house up to 200m3 reactor volume.